mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.3 |
0.02 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |